Expanded Access Program For Insmed’s Iplex Shows Power Of Patient Advocates At FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Lou Gehrig’s patients who appealed to the agency early will get access to drug; others enter a lottery system as part of a clinical trial.
You may also be interested in...
FDA Rules On INDs May Embolden More Patients To Ask For Trial Drugs
Pharma firms will see few policy changes following the publication of FDA's final regulations on expanded access to investigational medicine, but the revisions could nevertheless mean more patients and doctors will come knocking on their doors asking for experimental drugs
FDA Rules On INDs May Embolden More Patients To Ask For Trial Drugs
Pharma firms will see few policy changes following the publication of FDA's final regulations on expanded access to investigational medicine, but the revisions could nevertheless mean more patients and doctors will come knocking on their doors asking for experimental drugs
FDA Rules On Treatment INDs May Embolden More Patients To Ask For Trial Drugs
Agency expects individual patient INDs to rise by 50 percent as a result of new regs.